Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $38.0000 (-18.28%) ($38.0000 - $46.5000) on Mon. Oct. 21, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.61% (three month average) | RSI | 73 | Latest Price | $38.0000(-18.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 23.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(5%) PEJ(5%) EWP(4%) XAR(4%) XOP(4%) | Factors Impacting CAPR price | CAPR will decline at least -5.305% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.305% (StdDev 10.61%) | Hourly BBV | 0 () | Intraday Trend | -18.3% | | | |
|
5 Day Moving Average | $40.5(-6.17%) | 10 Day Moving Average | $35.15(8.11%) | 20 Day Moving Average | $31.42(20.94%) | To recent high | -18.3% | To recent low | 162.1% | Market Cap | $749m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |